Little is known about intracellular signaling mechanisms that persistently excite neurons in pain pathways. Persistent spontaneous activity (SA) generated in the cell bodies of primary nociceptors within dorsal root ganglia (DRG) has been found to make major contributions to chronic pain in a rat model of spinal cord injury ( 
Introduction
The mechanisms that maintain chronic pain after injury to either the peripheral or CNS are poorly understood, and these neuropathic pain mechanisms are inadequately targeted by available therapeutics (Cohen and Mao, 2014) . Permanent, intractable pain is often produced by spinal cord injury (SCI) (Finnerup, 2013; Walters, 2014) . Surprisingly, persistent pain-related behavior that develops in rats after contusive SCI at the thoracic level requires chronic, ongoing electrical activity in primary afferent neurons. This was shown by the reversal of behavioral measures of spontaneous and evoked pain produced by knocking down a voltage-gated Na ϩ channel, Nav1.8, which is uniquely expressed in primary afferent neurons and required for nociceptor SA (Yang et al., 2014) . SCI-induced chronic SA is especially prominent in the somata of C-fiber dorsal root ganglia (DRG) neurons, where it has been observed both in vivo and in small dissociated DRG neurons months after injury (Bedi et al., 2010) . Most of the DRG neurons with SA after SCI are nociceptors as indicated by their small size and frequent expression of TRPV1 and Nav1.8 channels (Bedi et al., 2010; Wu et al., 2013; Yang et al., 2014) . Given the strong evidence that SA generated in the somata of nociceptors contributes to chronic pain after SCI, it is important to define the mechanisms that persistently maintain this SA.
Persistent activity in the adenylyl cyclase (AC)-cAMP-protein kinase A (PKA) pathway has been suggested as a mechanism to maintain hyperexcitability in nociceptors for days or weeks after peripheral inflammation or injury (Aley and Levine, 1999; Liao et al., 1999; Song et al., 2006; Villarreal et al., 2009 ), but whether ongoing cAMP signaling contributes to pain-related hyperexcitability lasting months or longer in neuropathic conditions is unknown. Moreover, possible roles for macromolecular complexes that coordinate cAMP-dependent events, the nature of complexes that might be linked to nociceptor SA, and whether molecular regulation within the complexes is altered in nociceptors during any chronic pain conditions are unknown. Taking advantage of the fact that the SCI-induced SA that has been linked to chronic pain is retained in nociceptor somata after dissociation (Bedi et al., 2010; Wu et al., 2013; Yang et al., 2014) , we demonstrate that chronic SA in nociceptors requires continuing activity of AC and PKA, plus the presence of an intact complex of AC5/6, PKA, and the scaffolding molecule A-kinase anchoring protein 150 (AKAP150, also called AKAP79 in humans or AKAP5). These findings plus novel alterations found in the regulation of AC after SCI provide new insights into basic mechanisms that maintain SA in nociceptors and the consequent excitation of pain pathways.
Materials and Methods
All procedures complied with guidelines of the International Association for the Study of Pain and were approved by the institutional animal care and use committee. Male rats (200 -300 g) were maintained under a 12:12 h reversed light/dark cycle, and experiments were performed during the dark phase (Bedi et al., 2010) .
SCI procedures. Contusion injury and postsurgical care were conducted as described previously (Bedi et al., 2010) . Briefly, rats in the SCI group were deeply anesthetized with ketamine (80 mg/kg), xylazine (20 mg/kg), and acepromazine (0.75 mg/kg) before laminectomy of T10 vertebrae followed by a spinal impact using an Infinite Horizon impactor (150 kdyne, 1 s dwell time). Animals in the Sham group received identical surgery without spinal impact. Animals in the Naive group received no surgery. All SCI animals exhibited Basso, Beattie, and Bresnahan (BBB) hindlimb motor scores of 0 -1 (Basso et al., 1995) 1 d after SCI. Hindlimb motor function showed only partial recovery when examined before excision of DRGs 1-6 months after SCI, similar to that described previously (Bedi et al., 2010; Yang et al., 2014) .
Dissociation and culture of DRG neurons. Selected DRGs (L4, L5) were minced and incubated for 40 min at 34°C with trypsin (0.3 mg/ml) and collagenase D (1.5 mg/ml). DRG fragments were triturated, the neurons were plated without serum or growth factors onto 8 mm glass coverslips coated with poly-L-ornithine, and kept overnight in DMEM Ͻ5% CO 2 , 95% humidity at 37°C.
Recording from dissociated DRG neurons. Whole-cell patch recordings of SA were made at ϳ23°C from small neurons (soma diameter Յ30 m and input capacitance Յ45 pF) 18 -28 h after dissociation using a MultiClamp 700B amplifier (Molecular Devices) as described previously (Bedi et al., 2010; Wu et al., 2013) . Patch pipettes were pulled from borosilicate glass capillaries with a P-97 puller (Sutter) and fire polished to achieve a final electrode resistance of 3-8 M⍀. Pipettes were filled with solution containing the following (in mM): 134 KCl, 1.6 MgCl 2 , 13.2 NaCl, 3 EGTA, 9 HEPES, 1 Mg-ATP, and 0.3 Na-GTP (pH 7.2 adjusted with KOH, 300 mOsM, adjusted with sucrose). The bath solution contained 140 NaCl, 3 KCl, 1.8 CaCl 2 , 2 MgCl 2 , 10 HEPES, and 10 glucose (pH 7.4 adjusted with NaOH, osmolarity 320 mOsM). After forming a tight seal (Ͼ1 G⍀), the membrane was ruptured. After whole-cell configuration was established under voltage clamp, the input capacitance was measured, and then capacitance and series resistance were electronically compensated. The calculated liquid junction potential was 4.3 mV and was not corrected. Spontaneous activity (SA) was measured in current-clamp mode, beginning 2 min after membrane rupture. In previous studies, we defined SA as at least 1 spike occurring within 60 s (i.e., minimum firing rate of 0.02 Hz) (Bedi et al., 2010) . Because a demonstration of inhibitory effects on SA is impractical in cells with very low firing rates, in the current study we selected for neurons having initial SA firing rates of 0.1-5 Hz. For in vitro superfusion of DRG neurons with inhibitory or inactive control agents, solutions were driven by gravity from a set of independent tubes connected to an array of fused silica columns (inner diameter, 200 m). Rapid exchange of solutions was achieved by shifting the columns horizontally with a micromanipulator. The distance from the column mouth to the recorded cell was ϳ100 m. A subset of neurons was recorded with the perforated patch method to achieve stable recordings for much longer periods. Recordings were made with gramicidin (50 g/ml) in the recording pipette following established procedures (Wu et al., 2013; Zhu et al., 2014) . The PKA inhibitors, ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89), Rp-cAMPs, and the AC inhibitor 2Јde-oxyadenosine 3Ј-monophosphate (2Јdeoxy-3ЈAMP) were purchased from Sigma-Aldrich. The AKAP disrupting peptide stHt31 and its control stHt31P were purchased from Promega. Electrophysiological data were analyzed using PatchMaster, Clampfit version 10.4 (Molecular Devices) and Origin 5.0 (MicroCal Software).
Antibodies used for immunoprecipitation and Western blotting. These were mouse or rabbit anti-AKAP150 (EMD Millipore for Western blotting and Santa Cruz Biotechnology for immunoprecipitation) (Hoshi et al., 2003) , mouse anti-AKAP12 (Sigma-Aldrich, clone JP74) (Havekes et al., 2012) , mouse anti-PKA RII␤ (BD Transduction Laboratories) (Hoshi et al., 2003) , mouse anti-␤-actin (Santa Cruz Biotechnology), and normal mouse or rabbit IgG (Santa Cruz Biotechnology). The mouse anti-AC5 hybridoma cell lines were generated by Genscript against human AC5 peptide CGNQVSKEMKRMGFEDPKDKN (Hu et al., 2009) . Antibodies were purified by affinity chromatography using antigen immobilized peptide and are highly selective for AC5 over AC6 (data not shown).
RT-PCR of AC isoforms. Fresh DRGs or RNA later-stabilized DRGs were homogenized on ice using a conventional rotor-stator homogenizer (RNase-free). Total RNA was extracted using RNeasy Mini Kit (QIAGEN) according to the protocol suggested by the manufacturer. The RNA was eluted with RNase-free water and quantitated using the NanoDrop 1000 spectrophotometer. First-strand cDNA was generated from DNase-treated total RNA (250 ng-600 ng) using Moloney murine leukemia virus reverse transcriptase (New England Biolabs) and oligo(dT) primers. qRT-PCR was performed using an Eppendorf Mastercycler ep realplex 2 (Eppendorf) in the presence of SYBR Green I. Primers to rat AC isoforms 1-9 (Table 1 ) and rat GAPDH as the control were designed with NCBI Primer-Blast or using published sequences (Bek et al., 2001; Landa et al., 2005) . The 10 ng cDNA template was used in each reaction, performed in triplicate for each primer set. The cycling conditions were as follows: 2 min at 94°C followed by 40 cycles of 15 s at 94°C, 0.5 min at 60°C, and 0.5 min at 72°C. The fold change in transcript levels (2 ⌬⌬Ct ) between SCI and Sham control samples was calculated from the cycle times (C t ) of each primer set as follows, where ⌬⌬Ct ϭ ⌬Ct (ACX SCI Ϫ GAPDH SCI ) Ϫ ⌬ct(ACX Sham Ϫ GAPDH Sham ). Statistical analysis was performed according to Rieu and Powers (2009) . Amplified PCR products were run on 1.5% agarose gels after 35-40 cycles. Products for AC6 and AC8 were detected by agarose gels upon longer cycles and also with alternate primers (AC8Ј); AC1 and AC4 product levels were very low, and AC7 was below the level of detection for qRT-PCR. All primers were confirmed using rat brain tissue.
Immunoprecipitation of AC activity. DRGs below the vertebral T10 injury level from sham or SCI rats were used for all biochemical assays. Previous work showed similarly high incidence of SA after SCI in small neurons from DRGs from just above the injury level (T8, T9), at the injury level (T10, T11, T12), and below the injury level (L3 to L6) (Bedi et al., 2010; unpublished observations) . Thus, to maximize the amount of relevant DRG tissue, we pooled DRGs bilaterally from T12 to L6. Immunoprecipitation of protein complexes with rabbit IgG (control) or anti-AKAP150 antibodies was performed as described previously Kapiloff et al., 2009; Efendiev et al., 2013) . Disrupting peptides (10 -20 M) were added during homogenization and were prepared as described previously (Efendiev et al., 2010) . Immunoprecipitations were assayed for associated AC activity upon stimulation with 100 nM GTP␥S-G␣s and 50 M forskolin for 10 min at 37°C. AC8 activity was measured upon stimulation with 100 M Ca 2ϩ and 300 nM calmodulin. Acetylated cAMP was detected by enzyme immunoassay (ELISA kit from Enzo Life Sciences).
AC activity in DRG membranes. Freshly isolated DRGs were rinsed with PBS and resuspended in sucrose supplemented buffer: 20 mM HEPES, 1 mM EDTA, 2 mM MgCl 2 , 1 mM DTT, 250 mM sucrose, and protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM N␣-p-tosyl-L-lysine chloromethyl ketone, and 0.1 mM N-tosyl-L-phenyl alanine chloromethyl ketone). Tissue was homogenized using a rotor-stator tissue homogenizer (5 mm probe; 3 s pulses on ice, 7 times) and centrifuged at 1800 ϫ g to pellet nuclei. Membranes were subjected to centrifugation for 20 min at 60,000 ϫ g, resuspended in sucrose supplemented buffer, and analyzed for protein concentration by Bradford assay. Membranes (6 -10 g/reaction) were immediately assayed for AC activity upon stimulation with the indicated reagents (Dessauer, 2002) . Heart membranes were prepared from Naive/Sham or SCI animals as described above for DRGs, except that flash frozen tissue was rapidly thawed and quartered before homogenization. Membranes from Sf9 cells expressing AC1 or AC5 were prepared as described previously (Dessauer, 2002) .
Statistical analysis. Data are presented as mean Ϯ SEM. Comparisons were made with paired or unpaired t tests, one-way ANOVA followed by Bonferroni's post hoc tests corrected for multiple comparisons, or twoway ANOVA with repeated measures. SA incidence was compared using Fisher's exact tests. In many of the biochemical studies, specific a priori predictions based on published or unpublished pilot studies were tested between selected pairs of groups using t tests. Each group used for biochemical comparisons included at least three experiments, with each experiment performed in duplicate or triplicate. Statistical analyses were performed with Prism 6 (Graphpad Software).
Results
Activity of anchored PKA is required for persistent SCIinduced SA in DRG neuron somata We first asked whether continuing PKA activity is required for the maintenance of SCI-induced SA in small DRG neurons. SA occurs in the somata of numerous nociceptors at and below the injury level for at least half a year after thoracic spinal contusion, and its incidence is correlated with pain-related behavior (Bedi et al., 2010) . Importantly, SCI-induced nociceptor SA is abolished by interventions that reverse behavioral signs of pain (Wu et al., 2013; Yang et al., 2014 ). As we found previously, SCI significantly increased the incidence of L4/L5 neurons with SA (Fig. 1A ) compared with neurons in Naive or Sham groups (Fig. 1B , top bars): increased SA was found both 3 d after SCI (SA in 11 of 14 neurons, 79%) and 1-6 months after SCI (23 of 32 neurons, 72%). No significant differences in SA incidence were found between neurons tested 3 d versus 1-6 months after SCI in any of the SCI groups, regardless of treatment after dissociation, so early and late test data were combined for each group (more than half of each group shown was tested 1-6 months after SCI). The increase in SA incidence after SCI was associated with significant depolarization of resting membrane potential (RMP) (Fig. 1B , bottom bars) (see also Bedi et al., 2010) .
Previous work implicated ongoing PKA activity in the maintenance of hyperexcitability of small DRG neuron cell bodies (Song et al., 2006; Zheng et al., 2007) and in the induction of one type of hyperalgesic priming (Araldi et al., 2015a,b) . We found that bath application of Rp-cAMPS (100 M, applied at least 30 min before establishing whole-cell configuration) significantly decreased the incidence of SA in DRG neurons dissociated from DRG in SCI animals, and tended to hyperpolarize RMP ( Fig.  1 A, B) . To determine whether a PKA inhibitor would also reduce ongoing SA from a dissociated DRG neuron, we superfused a more membrane-permeant inhibitor, H-89 (50 M), over individual cells beginning 2-4 min after establishing whole-cell configuration. As shown in Figure 1 , C and D, spontaneous discharge in the small DRG neurons we sampled was irregular and showed considerable variability within and between cells (see also Bedi et al., 2010) . SA firing rates tended to increase during the first minute of whole-cell recording and then stabilize. H-89 applied when firing had stabilized (n ϭ 6) produced a decrease in firing rate within 40 s, and SA was essentially eliminated after 2 min of superfusion. Little or no recovery occurred within 3-5 min of washout (n ϭ 4, data not shown). Two-way ANOVA with repeated measures revealed significant effects of time after superfusion (F (12,168) ϭ 2.53; p ϭ 0.0044), 50 M H-89 treatment (F (1,14) ϭ 5.51; p ϭ 0.0341), and their interaction (F (12,168) ϭ 2.59; p ϭ 0.0035). Identical experiments using 10 M H-89 under whole-cell patch recording conditions (n ϭ 3) failed to reduce SA within 5 min (data not shown). Because membrane-permeant PKA antagonists such as H-89 are typically bath applied at least 10 min before electrophysiological recording, and it is difficult to maintain cell health for 10 min or more with the whole-cell patch configuration, we used the much less damaging (but more technically difficult) perforated patch method to test the possibility that the lower 10 M concentration of H-89 would suppress SA if allowed more time to penetrate into the cell. In small DRG neu- rons showing stable perforated patch recordings for long periods (25-75 min, n ϭ 3), 10 M H-89 produced clear, prolonged suppression of SA within 5-10 min of extracellular application (Fig. 1E) .
PKA is often targeted to signaling complexes by specific binding to AKAPs. We tested the necessity of this interaction by using a stearated AKAP-PKA disrupting peptide, stHt31, to inhibit the interaction between AKAPs and the regulatory subunits of PKA. Intracellular dialysis of stHt31 (50 M) through the pipette (in the whole-cell patch configuration) into neurons isolated from SCI animals significantly reduced the incidence of neurons displaying SA, whereas an inactive version of this peptide, stHt31P (50 M), had no effect ( Fig. 1 A, B) . As a complementary approach, we used STAD-2, a stable "hydrocarbon-stapled" PKA-AKAP disrupting peptide that is highly selective for the RII regulatory subunit of PKA (Wang et al., 2014) . Intracellular delivery of STAD-2 (500 nM) significantly reduced SA incidence and hyperpolarized the RMP, compared with effects of the scrambled inactive version, Scr-STAD ( Fig. 1 A, B) . For both stHt31 and STAD-2, the inhibitory effects were very rapid. The cells lacking SA exhibited no SA at any point during the recording session, even at the onset (30 -60 s after establishing whole-cell configuration). Moreover, the few cells with SA did not show a progressive decrease in firing rate after breaking into the cell. These observations suggest that, at these concentrations and with the 30 -60 s delay between break-in and recording onset, the inhibitors had an all-or-none effect on recorded SA. To observe the development of the predicted inhibition of ongoing SA, we used a lower concentration of inhibitor applied through a smaller aperture patch pipette. We found 4 neurons that exhibited SA when recordings began 15-30 s after break-in using a patch pipette containing 100 nM STAD-2 (instead of 500 nM) and having a resistance of 7-12 M⍀ (instead of 3-6 M⍀). In each case, the early SA was abolished within 100 s of break-in, as illustrated in Figure 1C , and no further SA occurred for the remainder of the recordings (2-10 min of inactivity). These results confirm that ongoing SA observed in small dissociated DRG neurons after SCI is blocked by disruption of AKAP-PKA interactions.
Interestingly, even at the higher concentrations used in most of our recordings, neither STAD-2 nor stHT31 completely eliminated SA in the sampled populations. Indeed, the SA incidence in the presence of these inhibitors was about the same as in cells sampled from Naive and Sham groups (Fig. 1B) . Moreover, neither inhibitor caused the DRG neurons to become inexcitable; artificial injection of depolarizing current in the presence of either inhibitor was still able to evoke action potentials (data not shown). Together, these results indicate that ongoing activity of PKA anchored by the RII subunit to an AKAP is continuously required for the generation of persistent SA in isolated nociceptors induced by prior SCI, but this activity is not required for normal excitability.
AC5/6 complexed with AKAP150 is required for persistent SCI-induced SA
The requirement of anchored PKA activity for persistent SCIinduced SA implied that AC activity is also necessary. Using intracellular dialysis of the AC P-site inhibitor, 2Јdeoxy-3ЈAMP (300 M), we found significant reduction of SA incidence and significant hyperpolarization in small sensory neurons from SCI rats compared with neurons dialyzed with vehicle ( Fig. 2A) . To obtain a complete profile of AC isoform expression, we used qRT-PCR to compare DRG transcript levels between Sham and SCI groups. Largely in accord with previous studies (Ehnert et al., 2004) , AC2, AC3, AC5, and AC9 were detected in DRGs taken from T12 to L6 segments and, to a lesser extent, AC6 and AC8 (Fig. 2B) . Relatively small differences in RNA levels for any AC isoform were found between SCI and Sham groups, although AC6 was significantly elevated and AC8 was significantly reduced in the SCI preparations (Fig. 2C) .
Most small DRG neurons that exhibit SA after SCI express TRPV1 (Wu et al., 2013) . In nociceptors, TRPV1 is complexed with AKAP150 and AC5 and/or AC6 (Efendiev et al., 2013) . Therefore, we probed this complex using an AC-AKAP150 disrupting peptide that is selective for the AC5/6 binding domain of AKAP150 (AKAP79 , hereafter called AC-AKAPi) (Efendiev et al., 2010 (Efendiev et al., , 2013 . We have previously shown that AC-AKAPi is selective for AC5/6 and does not displace AC2 or AC9 from the AKAP79/150 scaffold (Efendiev et al., 2010) . AC3 and AC8 activity can also be immunoprecipitated with AKAP150 when overexpressed in HEK293 cells (Fig. 3A) (Efendiev et al., 2010) . AC-AKAPi (10 M) had no effect on AKAP150 anchoring of AC3 or AC8 but disrupted AC5 interactions with the scaffold ( Table 1 . C, qRT-PCR of AC isoform expression in DRGs from Sham and SCI rats. Fold change (2 ⌬⌬Ct ) after SCI Ϯ SD is plotted. All samples were normalized to GAPDH controls (n ϭ 3, performed in triplicate). For description of statistical analysis, see Materials and Methods. 3A). Our control peptide (AKAP79 109 -290 ) had no effect on the association of any AC isoform with AKAP79/150 (Fig. 3A ) (Efendiev et al., 2010) . To determine the level of AC activity associated with AKAP150 in SCI and Naive animals, we immunoprecipitated AKAP150, using IgG as a control, from lysates of DRGs taken from segments T12 to L6 followed by G␣s/forskolin-stimulated AC activity measurements. Antibodies against AKAP150 pulled down nearly fourfold increased AC activity compared with IgG in preparations from both SCI and Naive groups (Fig. 3B) . The disrupting peptide AC-AKAPi (20 M) significantly reduced AKAP150-associated AC activity obtained from both Naive and SCI groups (Fig. 3B) . As AC-AKAPi is selective for AC5 and AC6, and does not affect interactions of AKAP150 with other AC isoforms (Fig. 3A) (Efendiev et al., 2010) , these results indicate that most of the AC activity associated with AKAP150 in DRGs is produced by AC5/6.
To investigate the requirement of this complex for the maintenance of SCI-induced SA, we dialyzed small sensory neurons isolated from SCI rats with AC-AKAPi (20 M) or a control peptide, AKAP150
109 -290 (20 M), that does not affect AC-AKAP150 interactions. As found with the PKA-AKAP disrupting peptides, dialysis with AC-AKAPi caused a significant decrease in SA incidence compared with the control peptide (Fig. 3C ), albeit with no apparent effect on RMP. This result strengthens the conclusion that AC5/6-AKAP150 interactions are required for persistent nociceptor SA.
Previous studies have identified expression of several AKAPs in nociceptors, including AKAP150, AKAP12 (also known as Gravin), AKAP18, and Yotiao (Schnizler et al., 2008) . Western blotting confirmed expression of AKAP150, AKAP12, and the RII␤ subunit of PKA in DRGs, but the protein levels were largely unchanged after SCI (Fig. 3D) . A small but significant increase in AKAP150 was detected after SCI. AC5 protein levels were also unchanged (Fig. 3D) ; limited amounts of DRG tissue and inadequate quality of antibodies to other AC isoforms prevented detection of other AC isoforms.
SCI alters the regulation of ACs in DRGs
An important question is whether SCI alters the function of the AC5/6-AKAP150-PKA complex. A persistent functional change in this complex could be important for driving chronic SA and consequent pain. To begin to address this question, we looked for SCI-induced modifications in the regulation of AC activity in membranes isolated from DRGs taken from T12 to L6 segments in control (Naive and Sham) and SCI rats. AC activity measurements were made under basal enzyme conditions, during stimulation with purified GTP␥S-bound G␣s (100 nM) either in the presence or absence of GTP␥S-G␣i (1 M), and upon stimulation with Ca 2ϩ /calmodulin (100 M/300 nM; Fig. 4A ). Membranes from Naive (n ϭ 2) and Sham (n ϭ 2) rats showed identical response patterns, so these control data were pooled. Previous associated stimulated AC activity was measured (mean Ϯ SEM, n ϭ 3 performed in duplicate, normalized to control peptide with AKAP150). *p Ͻ 0.05 (paired t test on non-normalized data). **p Ͻ 0.01 (paired t test on non-normalized data). B, AKAP150-associated AC activity is reduced by AC-AKAPi in DRGs from sham and SCI rats. Samples were immunoprecipitated with control IgG or anti-AKAP150 in the presence or absence of AC-AKAPi (20 M), and associated AC activity was measured (mean Ϯ SEM, n ϭ 3). ***p Ͻ 0.001 (unpaired t test). C, Attenuation of SCI-induced SA by AC-AKAPi. *p Ͻ 0.05 (Fisher's exact test). D, F, AKAP150, but not AC5, protein expression in DRGs is slightly enhanced by SCI (mean Ϯ SEM, n ϭ 3-5). *p Ͻ 0.05 (paired t test of SCI vs Sham controls). E, Characterization of anti-AC5. WB of membranes from Sf9 cells expressing AC3, AC5, or AC6. n.s., Not significant. studies have failed to find significant differences in nociceptor physiology or pain-related behavior between Naive and Sham animals (Bedi et al., 2010; Wu et al., 2013; Yang et al., 2014) . G␣s produced an eightfold increase in activity, which was inhibited 60% by the presence of G␣i. This pattern indicates major contributions from AC5/6, which are activated by G␣s, inhibited by G␣i, and unaffected by Ca 2ϩ /calmodulin. Stimulation by Ca 2ϩ /calmodulin alone caused a 1.5-fold enhancement of basal AC activity, suggesting weak contributions from AC1, AC3, and/or AC8.
Importantly, DRG membranes isolated from SCI animals (n ϭ 4) showed significant differences in AC regulation compared with membranes from the control animals; there was a dramatic loss of G␣i inhibition and a 1.5-fold increase in AC activity stimulated by Ca 2ϩ /calmodulin (Fig. 4A) . SCI had no significant effect on the total basal or G␣s-stimulated AC activity. This alteration in AC regulation after SCI was not a generalized effect of SCI, as no alterations in G␣i inhibition or Ca 2ϩ /calmodulin stimulation were detected in heart tissue from SCI groups compared with Naive/Sham groups (Fig. 4B) . Examples of AC regulatory patterns are shown as controls in Figure 4C , where membranes from Sf9 cells expressing AC1 or AC5 were assayed under the same regulatory conditions as above. Although both AC isoforms were inhibited by G␣i (35% and 58% for AC1 and AC5, respectively), only AC1 (and AC8, data not shown) was activated by Ca 2ϩ /calmodulin (10-fold). These findings suggest that SCI-induced alterations in the regulation of ACs, especially AC5/6, are important for driving PKA activity and promoting nociceptor SA.
Discussion
This study has revealed a previously unsuspected role for AC5 and/or AC6 complexed with AKAP150 and PKA in maintaining nociceptor hyperactivity after SCI, and has disclosed novel alterations of AC function that have not been reported previously in any physiological context. Increases in cAMP synthesis in primary afferent neurons have long been known to participate in various responses to bodily injury, including axonal regeneration (Siddiq and Hannila, 2015) and sensitization (Gold and Gebhart, 2010) . In nociceptors, increased cAMP synthesis contributes to sensitization by inflammatory signals lasting several hours (e.g., Taiwo et al., 1989; Cui and Nicol, 1995; Hingtgen et al., 1995; Kress et al., 1996; Gold et al., 1998) , and the acute sensitization of nociceptors by heat or prostaglandin E 2 depends upon AKAP150-PKA complexes (Jeske et al., 2008; Schnizler et al., 2008; Efendiev et al., 2013; Fischer and McNaughton, 2014) . Surprisingly few studies have investigated whether AC-PKA signaling also contributes to the maintenance of persistent hyperexcitability of nociceptors. Inhibitors of PKA activation or AC activity can reduce nociceptor hyperexcitability when applied days or weeks after nerve crush (Liao et al., 1999) , peripheral prostaglandin E 2 injection (Aley and Levine, 1999; Villarreal et al., 2009) , or "chronic" (1-2 weeks) compression of lumbar DRGs (CCD model) (Song et al., 2006; Zheng et al., 2007; . Inhibition of PKA activity by H-89 has been reported to block the induction of hyperalgesic priming (lasting several weeks) by agonists of mu opioid receptors (Araldi et al., . SCI reduces G␣i inhibition of AC activity in DRG membranes and increases Ca 2ϩ / calmodulin-stimulated activity without changing basal or total G␣s-stimulated AC activity. AC activity was measured in membranes prepared from (A) DRGs (n ϭ 4), (B) heart (n ϭ 3), or (C) Sf9 cells expressing AC1 or AC5 (n ϭ 3) under basal conditions or in the presence of G␣s 4 (100 nM), G␣s plus G␣i (1 M), or Ca 2ϩ /calmodulin (CaM; 100 M/300 nM). *p Ͻ 0.05 (unpaired t tests). **p Ͻ 0.01 (unpaired t tests). ***p Ͻ 0.001 (unpaired t tests).
# Significant difference in CaM-stimulated AC responses of SCI versus Naive/Sham animals. NS, Not significant.
